Get started
Author

Jayne Galinsky

Observed names: Galinsky, J, Galinsky, Jayne, J Galinsky, J. Galinsky
ORCID: 0009-0003-6047-0098
Observed ORCID: 0009-0003-6047-0098
OpenAlex ID: A5022154792
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
2023 · Madeline Pe, Ahu Alanya, et al. · The Lancet Oncology · 67
PDF
Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma
2017 · Douwe Postmus, Sarah Richard, et al. · The Oncologist · 64
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study
2021 · Rosanne Janssens, Tamika Lang, et al. · Frontiers in Medicine · 44
PDF
Myeloma Patient Value Mapping: A Discrete Choice Experiment on Myeloma Treatment Preferences in the UK
2020 · Simon Fifer, Jayne Galinsky, et al. · Patient Preference and Adherence · 26
PDF
Productivity losses in patients with newly diagnosed multiple myeloma following stem cell transplantation and the impact of maintenance therapy
2019 · Graham Jackson, Jayne Galinsky, et al. · European Journal Of Haematology · 21
PDF
The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes
2025 · Josien C.C. Scheepens, Mogens Groenvold, et al. · European Journal of Cancer · 11
PDF
What matters most to patients with multiple myeloma? A Pan-European patient preference study
2022 · Rosanne Janssens, Tamika Lang, et al. · Frontiers in Oncology · 11
PDF
Regenerative medicine: Stroke survivor and carer views and motivations towards a proposed stem cell clinical trial using placebo neurosurgery
2017 · Nicola A. Cunningham, Purva Abhyankar, et al. · Health Expectations · 11
PDF
What do families, staff, and stakeholders think about children’s dream fulfilment?
2014 · Jayne Galinsky · Issues in Comprehensive Pediatric Nursing · 6
Myeloma patients’ self-reported experiences of care and treatment
2016 · Jayne Galinsky, Sarah Richard, et al. · Cancer Nursing Practice · 5
How people with myeloma perceive patient-reported outcome measures
2019 · Jayne Galinsky, Sarah Richard · Cancer Nursing Practice · 4
Pf717 Quality of Life (qol), Perspectives on Treatment and Important Outcomes for Multiple Myeloma (mm) Patients and Their Carers: a Mixed Methods Evidence Synthesis
2019 · C. Kerr, K. Stubbs, et al. · HemaSphere · 2
MSR21 Methodological Aspects of a COVID-19 Vaccine Discrete Choice Experiment Survey in Canada, Germany, UK, and US General Populations
2023 · S. Sri Bhashyam, H.B. Lewis, et al. · Value in Health · 1
PDF
1371. Results From the COVID-19 Vaccines Discrete Choice Experiment Pre-Test Qualitative Interviews in Canada, Germany, the UK, and US General Population
2023 · Sumitra Sri Bhashyam, L G Shane, et al. · Open Forum Infectious Diseases · 1
MM-200: A Qualitative Study of Patients’ Preferences for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, and Germany
2021 · Caitlin Thomas, Heather Gelhorn, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
A grounded theory study of dream fulfilment in children and young people with life-threatening and long-term conditions and their families
2015 · Jayne Galinsky · Stirling Online Research Repository (University of Stirling) · 1
PDF
Patient Perspectives on Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Attributes
2026 · Nisith Kumar, Joshua Coulter, et al. · Cardiology and Therapy
PDF
Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials
2026 · Josien C.C. Scheepens, Luigi Lim, et al. · European Journal of Cancer
PDF
Construct validity and responsiveness to change of the EORTC QLQ-C30 Summary Score: an analysis of six closed EORTC trials
2026 · Josien Scheepens, Luigi Lim, et al. · SSRN Electronic Journal
The use of the EORTC QLQ-C30 Summary Score in clinical cancer research: guidance from the EORTC Quality of Life Group
2026 · Josien Scheepens, Mogens Groenvold, et al. · SSRN Electronic Journal
Diverse preferences for treatment options in relapsed/refractory (R/R) follicular lymphoma (FL): Survey results from patients in the United States (US)
2025 · Krish Patel, Esprit Ma, et al. · Blood
P17.38.b the Use of Eortc Qlq-c30 Summary Score in Cancer Clinical Trials and Its Performance as Compared With the Global Health / Quality of Life Scale: a Comparative Analysis of Effect Sizes
2025 · J Scheepens, M Groenvold, et al. · Neuro-Oncology
PDF
563 | Patient Preferences for Relapsed/refractory Follicular Lymphoma in the Novel Treatment Era: Interim Survey Results
2025 · K. Patel, E. Ma, et al. · Hematological Oncology
PDF
HPR128 Use of Clinical Outcomes Assessments (COAS) By Hospitals in the USA, UK, France and Sweden: Multi-Stakeholder Viewpoints
2023 · R. Sherafat, K. Conway, et al. · Value in Health
PDF
P53 Patient Preferences for Multiple Myeloma Treatment: A Stated Preference Survey Using Discrete Choice Experiment and Swing Weighting
2022 · R. Janssens, T. Lang, et al. · Value in Health
PDF
Works count: 36
Citation count: 276
H-index: 8
I10-index: 8
Year
Topic
Type